Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4749191 | 5867328 | I | 4749191-3 | 20030101 | 20050801 | 20050817 | EXP | 20050803523 | JOHNSON + JOHNSON PHARMACEUTICAL | 45 | YR | F | N | 20050801 | 20030101 | GREECE |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4749191 | 1006337946 | PS | DOXORUBICIN HCL | 1 | 30 MG /M2 | D | D | 50718 | |||
| 4749191 | 1006358446 | SS | DOCETAXEL | 2 | 75 MG/M2 | D | D |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4749191 | 1006337946 | BREAST CANCER METASTATIC |
| 4749191 | 1006358446 | BREAST CANCER METASTATIC |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4749191 | DE |
| 4749191 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 4749191 | ALOPECIA |
| 4749191 | BREAST CANCER |
| 4749191 | DRUG INTERACTION POTENTIATION |
| 4749191 | GENERALISED ERYTHEMA |
| 4749191 | HEMIPLEGIA |
| 4749191 | HYPERSENSITIVITY |
| 4749191 | METASTASES TO CENTRAL NERVOUS SYSTEM |
| 4749191 | METASTASES TO SKIN |
| 4749191 | NEUTROPENIA |
| 4749191 | PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
| 4749191 | RESPIRATORY DISORDER |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4749191 | FGN |
| 4749191 | LIT |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4749191 | 1006337946 | 20021201 | 20030201 | ||
| 4749191 | 1006358446 | 20021201 | 20030201 |